| Visualizaciones | |
|---|---|
| Use of ocrelizumab in patients with primary progressive multiple sclerosis | 19 |
| junio 2024 | julio 2024 | |
|---|---|---|
| Use of ocrelizumab in patients with primary progressive multiple sclerosis | 13 | 6 |
| Visualizaciones | |
|---|---|
| trealu_a2023_gibert_clàudia_caracterització_esclerosi_MOD.pdf | 3 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 8 |
| China | 3 |
| España | 2 |
| Reino Unido | 1 |
| Visualizaciones | |
|---|---|
| Menlo Park | 4 |
| Guangzhou | 2 |
| Jackson | 2 |
| Barcelona | 1 |
| Houston | 1 |
| Jiaxing | 1 |
| Mountain View | 1 |
| Seseña Nuevo | 1 |